Through complementation of mutations specifically blocking the biosynthesis of tetracenomycin C by Streptomyces glaucescens and selecting for resistance to tetracenomycin C in Streptomyces lividans, all of the genes for the production of tetracenomycin C were inserted in pU702, a high copy-number Streptomyces gene cloning vector. The tcm biosynthetic and resistance genes occur as a single cluster in the S. glaucescens genome and are expressed in heterologous streptomycete hosts like S. lividans, resulting in the overproduction of pigmented intermediates of the tetracenomycin C biosynthetic pathway. Anthracycline antibiotics like daunorubicin (1) and doxorubicin (2) are widely used in cancer chemotherapy but not without severe toxicological problems (1) and with a high production cost due to the complex metabolite mixtures that are characteristic of the producing strains (2). Solutions to such problems should be found through studies of the genetics of anthracycline antibiotic production and application of the knowledge gained for strain improvement and the creation of additional anthracycline metabolites with increased potency or lessened toxicity. As a first step in these directions, we initiated a study of the genetics of tetracenomycin C (TcmC) production. TcmC (3) is an anthracycline antibiotic with significant antitumor activity (3) that is produced by Streptomyces glaucescens GLA.0 (ETH 22794), a genetically well-characterized streptomycete (4). The biochemical parallels in the biosynthetic pathways of compounds 1, 2, and 3 (5-7) may reflect an underlying genetic similarity and should enable the production of hybrid anthracycline antibiotics by genetic engineering.
Anthracycline antibiotics like daunorubicin (1) and doxorubicin (2) are widely used in cancer chemotherapy but not without severe toxicological problems (1) and with a high production cost due to the complex metabolite mixtures that are characteristic of the producing strains (2) . Solutions to such problems should be found through studies of the genetics of anthracycline antibiotic production and application of the knowledge gained for strain improvement and the creation of additional anthracycline metabolites with increased potency or lessened toxicity. As a first step in these directions, we initiated a study of the genetics of tetracenomycin C (TcmC) production. TcmC (3) is an anthracycline antibiotic with significant antitumor activity (3) that is produced by Streptomyces glaucescens GLA.0 (ETH 22794), a genetically well-characterized streptomycete (4) . The biochemical parallels in the biosynthetic pathways of compounds 1, 2, and 3 (5-7) may reflect an underlying genetic similarity and should enable the production of hybrid anthracycline antibiotics by genetic engineering.
To set the stage for cloning the tcm genes, we isolated a set of TcmC-nonproducing mutants (6) and characterized the metabolites that accumulated in each mutant (7) . From the latter information and the cosynthetic properties of these mutants, we constructed a hypothetical pathway for the biosynthesis of compound 3 and determined the positions of 10 tcm mutations that blocked this pathway at several points (6) . Here we report the cloning of all of the genes required for TcmC biosynthesis through the complementation of the tcm mutations and the linkage between tcm biosynthetic and resistance genes. By examining the cloned tcm DNA, we show that the production and resistance genes form a single cluster in S. glaucescens and are expressed in heterologous streptomycete hosts.
MATERIALS AND METHODS
Bacteria, Plasmids, and Growth Media. The strains of S. glaucescens used in this study are described in ref. 6 . Streptomyces lividans TK 24 (8) (11) , and protoplasts of this strain were regenerated on R2YE medium (11) . Strains transformed with pIJ702 and its derivatives were grown under selection with thiostrepton (50 ,ug/ml).
DNA Isolation. Chromosomal DNA was isolated from S. glaucescens by the method of Hopwood et al. (11) . Plasmid DNA was isolated by the minilysate method of Kieser (12) , which was scaled-up 10-fold for the preparation of large amounts of DNA.
Cloning Procedure. pIJ702t was completely digested with Bgl II and treated with calf intestine alkaline phosphatase (Boehringer Mannheim). Chromosomal DNA from S. glaucescens GLA.0 was partially digested with BamHI or Mbo I and size-fractionated on 10-40% sucrose gradients (11) Abbreviations: Tcm, tetracenomycin; ThioR, thiostrepton resistant.
tTo whom requests for reprints should be addressed.
tInsertional inactivation of the mel gene in pIJ702 (9) could not be used as preliminary determination of the cloning efficiency because all of the TcmC-mutants produced melanin.
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to an average size of 8-18 kilobase pairs (kb). Vector DNA Protoplasts of S. glaucescens TcmC-mutants and S. lividans TK 24 were prepared by minor modifications of the method of Hopwood et al. (11) , then transformed with 100-,ul aliquots of the ligation mixture and regenerated on R2YENG or R2YE plates following the protocols described for S. lividans (11) . After overnight incubation at 30'C, thiostrepton-resistant (ThiOR) transformants were selected by overlaying the regeneration plates with soft nutrient agar containing sufficient thiostrepton for a final concentration of 50 gg/ml, followed by growth at 30'C for 3-4 more days.
The ThioR colonies from the transformation of S. glaucescens strains were transferred onto master HickeyTresner sporulation plates (6) containing thiostrepton and R2YE plug plates (96-well microtiter plates). After 3-4 days incubation at 30'C, the plugs were screened for the TcmC' phenotype by bioassay with Streptomyces coelicolor M111 (hisAl uraAl strAl SCP1 SCP2*) as described (6 when an identical number of transformants of the GLA. (tcmIIf) strain or 3000 transformants of the GLA.5-1 (tcmIc) strain were screened. All the ThioR transformants were found to be TcmC+ upon retransformation of GLA.4-48 with plasmid DNA isolated from the 3 clones, thus confirming the presence of DNA complementing the tcmII mutation in the recombinant plasmids.
Restriction mapping of these plasmids established the presence of 6.9-, 7.9-, and 12.15-kb DNA inserts in plasmids pHM49, pHM10, and pHM57, respectively ( Fig. 1 A-C) . The insert in pHM10 overlapped that of pHM49 and was located in the same relative orientation in the vector. pHM57 contained the same insert as pHM10, but in the opposite orientation relative to vector DNA, and also had a 0.45-kb extension to the right and a 3.8-kb extension to the left of this insert.
A TcmC sensitive strain, S. lividans TK 24 (8) , was used as the host to clone the tcm resistance gene by using pIJ702 with Mbo I-digested GLA.0 DNA inserted into its Bgl II site.
Three different plasmids were obtained from five TcmCresistant clones and designated as pHM151 (one isolate), pHM152 (two isolates), and pHM153 (two isolates). After confirming by retransformation that these three plasmids carried the tcm resistance gene, restriction mapping showed ( Fig. iF ) that pHM153 contained a 5-kb DNA insert that was also present in the opposite orientation in pHM151. Plasmid pHM151 had an 8.05-kb insert representing a 2.05-kb extension to the left and a 1-kb extension to the right of the insert in pHM153 (Fig. 1E) . pHM152 carried the entire insert of pHM151 in the same orientation plus a 4-kb extension to its right (Fig. 1D) .
Complementation Patterns of the tem Clones. To learn if the plasmids isolated from the 6 clones carried other tcm genes, representatives of the 10 TcmC-mutants identified (6) were transformed with each of the 6 plasmids, and the transformants were scored for the TcmC' phenotype. pHM49 strongly complemented the tcmIa, -Id, -II, -IV, and -V mutations but only weakly complemented the tcmVI mutation (Table 1) as judged by the size of the zone of growth inhibition. pHM10 showed a similar complementation profile indicating that its 1 kb of extra DNA does not encode any detectable functions. Both plasmids complemented the tcmIb mutation in only 5-10% of the transformants tested. This implies that each of these plasmids contained only a part of the temIb gene, the less-than-complete complementation possibly resulting from the need for recombination with the genomic DNA to observe the TcmC' phenotype (14) . pHM57, which contains the largest insert of GLA.0 DNA, complemented all seven of these tcm mutations (Table 1) to the same extent.
All three of the plasmids carrying the tcm resistance gene complemented the tcmVII mutation. pHM151 in addition complemented the tcmIc and tcmIII mutations in 30-50% of the cases. This plasmid was very unstable in all of the TcmCmutants except for GLA.4-16 (tcmVII). Plasmid pHM152 could not be maintained in any of the TcmC-strains. Despite our inability to verify this directly because of its instability, pHM152 should have a complementation profile similar to pHM151 since it carries the same insert plus some additional DNA. All three of these plasmids were relatively stable in the TK 24 strain.
Clustering of tem Genes. The possibility that the 0.45-kb BamHI fragment on the right end of the pHM57 insert (Fig.  1C) was the same as the BamHI fragment on the left end of the pHM152 (Fig. ID) and pHM151 (Fig. 1E) inserts was tested by Southern hybridization. A 2-kb Sst I-Kpn I fragment (sites 24 to 29 of Fig. 1 ), which contains -300 base pairs of the presumptive overlapping sequence, was labeled with biotinylated dUTP and used to probe different restriction digests of pIJ702, pHM57, and pHM152 ( Fig. 2A) . Vector DNA did not hybridize with this probe; Sst I-Kpn I-digested pHM57 DNA hybridized only to a band of identical size as the probe, as expected; Sst I-Pst I-digested pHM152 DNA yielded a 1.9-kb fragment from a Pst I site in the vector through sites 28-32 (Fig. 1D ) that hybridized to the probe; and BamHI-digested pHM152 DNA gave a 1.8-kb fragment from a BamHI site in the vector through sites 28-30 (Fig. 1D ) that hybridized to the probe. Since these latter two fragments each contain the entire 0.45-kb fragment covering sites 28-30 in Fig. 1 , the results establish that the inserts of plasmids pHM57 and pHM152 share a 0.45-kb sequence of overlapping DNA as shown in Fig. 1 C and D. To see if the genomic organization of tcm DNA is identical to that of the cloned tcm DNA, the same probe was hybridized with BamHI and Xho I-EcoRI-digested GLA.0 DNA. Hybridizing fragments of =7 kb were seen in the BamHI digest (Fig. 2B) , which represents sites 15-28 in Fig.  1 , and of :8.3 kb in the Xho I-EcoRI double digest (Fig. 2B) , representing sites 17-36 in Fig. 1 . Since pHM152 contains the unique EcoRI site and no Xho I sites (Fig. 1D) Gene Cluster. Recombinant plasmid pHM57, when introduced into wild-type and TcmC-strains of S. glaucescens, caused the overproduction of an orange-red pigment that was identified by TLC and structural analysis (NMR, IR, and UV spectroscopy) as a mixture of the known metabolites TcmDl and TcmE (7). This finding suggested that pHM57 carried all of the genetic information for the production of TcmE, a relatively late intermediate of the TcmC biosynthetic pathway (6, 7). We tested this possibility by transforming Streptomyces ambofaciens ATCC 15154, Streptomyces lasaliensis NRRL 3382R, and S. lividans TK 24 with pHM57. The transformants all produced an orange-red pigment very early in their growth that was proven to be a mixture of TcmDl and TcmE (data not shown).
Since the overlapping inserts in pHM57 and pHM152 represent -24 kb of contiguous DNA from S. glaucescens, we wondered if this would be enough to encode the entire TcmC biosynthetic pathway. To examine this possibility, S.
lividans TK 24(pHM57) and TK 24(pHM152) transformants were grown in a mixed liquid culture, and, at 3 days, the culture was extracted with ethyl acetate to recover TcmC and similar metabolites (7) . TLC (Fig. 3 ) plus bioautography (data not shown) of this extract showed that TcmC, verified by chemical [conversion to the 3-ethoxy-3-demethoxy derivative of TcmC (7)] and spectral [IR, NMR, and UV (7) ta5% of the transformants were TcmC'.
tWeak complementation was observed. §These plasmids also conferred the TcmC-resistant phenotype to S.
lividans TK 24. analyses, and several related metabolites (TcmA2, -B, -D, and -E) were produced by the mixed culture and the wild-type GLA.O strain, whereas such compounds were not found in extracts of TK 24 and TK 24(pHM152) cultures. As noted above, TK 24(pHM57) produced TcmD1 and TcmE, the two metabolites that also are accumulated by the GLA.4-16 (tcmVII) mutant (6, 7) . The observation that all of the TcmC production genes reside in pHM57 and pHM152 was confirmed by a double transformation experiment. S. lividans TK 24(pHM57) was (pHM152), and TLC and bioautography of the ethyl acetate extract ofthis culture were carried out as described (6) . Tcm metabolites were identified by comparison with authentic reference standards (7).
transformed with plasmid pHM152, the transformed colonies were regenerated with selection for ThioR, and the primary transformants were screened for antibiotic production. TcmC was produced by 2-5% of these colonies (verified by the yellow color of young colonies plus TLC and bioautography of colony extracts), which was possible because cotransformation of TK 24(pHM57) with pHM152 provided the necessary resistance to TcmC. This property was lost upon serial transfer with selection for ThioR or for ThioR plus TcmC resistance, and the resulting colonies were shown to contain pHM57 only or pHM57 plus a small amount of pHM152, which indicates that segregation of the primary transformants had occurred without intermolecular recombination between the homologous regions in pHM57 and pHM152.
DISCUSSION
We chose to clone the tcm genes by complementation of tcm mutations in blocked mutants of S. glaucescens following the precedent set by Malpartida and Hopwood (17) with the cloning of the actinorhodin gene cluster from S. coelicolor. Since they showed that the act genes were clustered in one segment of DNA (17), we anticipated a similar result for the tcm genes. But it was not at all certain that the biosynthetic and resistance genes would be located in the same DNA region, even though at the outset of our work there were two indications that this could be the case (17) (18) (19) . That the tcm production and resistance genes are indeed clustered [and chromosomally located since the tcmVII mutation mapped between the S. glaucescens his-2 and met-2 loci (20) (E. Wendt-Pienkowski and C.R.H., unpublished data)] suggests that this is a common trait among the Streptomyces for their antibiotic production genes. Other discoveries (21) have confirmed this hypothesis with only one exception, the genes for the production of oxytetracycline that exist as two clusters in the Streptomyces rimosus genome (22) .
In contrast to the act genes (17), we were able to clone the tcm genes with the high copy-number vector pIJ702 in a homologous background. Nonetheless, we did encounter a severe instability of plasmids pHM1S1 and pHM152, which is the reason that only 30-50% of the pHM151 transformants exhibited complementation of the tcmIc and -III mutations.
Our failure to obtain TcmC' clones in the primary cloning experiment with the GLA.5-1 and 5-57 strains also must have been due to the instability of recombinant plasmids with DNA from the same region as in the inserts of pHM151 and pHM152. The relative stability of pHM153 and the isolation of a stable, deleted form of pHM151 that lacked the entire insert in this plasmid except for sites 28-31 (this deleted plasmid was isolated through complementation of the tcmIII mutation in GLA.5-47 with pHM151), suggests that the observed instability is due to a region of :1 kb around Sst I site 32 in Fig. 1 . DNA subcloned from this region in a low copy-number Streptomyces plasmid in S. lividans was also quite unstable, causing extensive deletions of vector DNA along with complete loss of insert DNA (unpublished data).
Expression of the production genes for two other antibiotics-actinorhodin (17) (Fig. 1 ) complements the tcmIa mutation%, which presumably blocks the first step in the TcmC pathway, formation of the polyketide precursor of TcmF (6, 7). The Bgl II fragment is homologous to the actI gene (25) , which corresponds to a mutation having the same effect on actinorhodin biosynthesis (26) . This result has been used along with other data to support a proposition for extensive sequence homology among "polyketide synthase" genes and to show the value of this homology in expediting the cloning of genes for the production of other polyketide maetabolites (25) . Availability of such polyketide synthase genes will enable studies of the genetic organization and enzymology of the complex polyketide biochemical systems found in bacteria, fungi, and plants. §Hunter, I. S., Sugden, D. A., Warren, M. & Butler, M. J. (1986) Fifth International Symposium on the Genetics of Industrial Microorganisms, Sept. [14] [15] [16] [17] [18] [19] [20] 1986 
